Literature DB >> 16328364

Burkholderia pseudomallei infection in chronic granulomatous disease.

Raffaele Renella1, Jean-Marie Perez, Sylvie Chollet-Martin, Sabine Sarnacki, Alain Fischer, Stéphane Blanche, Jean-Laurent Casanova, Capucine Picard.   

Abstract

Melioidosis is a severe illness caused by Burkholderia pseudomallei, a sepsis-causing bacterial pathogen that is common in East Asia. We reexamined the underlying diagnosis in a 12-year-old boy who was diagnosed in the French West Indies with melioidosis when he was 4 years old. Our investigations led to the determination of chronic granulomatous disease (CGD), an inherited condition characterized by phagocytic cell dysfunction. This is the third reported case of melioidosis associated with CGD to be reported, lending support to an association between the two. The molecular determinants of the susceptibility of CGD patients to B. pseudomallei are still unknown. Our report suggests that CGD should be suspected in children with melioidosis, both in the Americas and probably in other regions world-wide.

Entities:  

Mesh:

Year:  2005        PMID: 16328364     DOI: 10.1007/s00431-005-0022-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  First case report of melioidosis in Guadeloupe, a French West Indies archipelago.

Authors:  J M Pérez; A Petiot; C Adjidé; F Gerry; R Goursaud; B Juminer
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

2.  Melioidosis and chronic granulomatous disease.

Authors:  M J Tarlow; J Lloyd
Journal:  Proc R Soc Med       Date:  1971-01

Review 3.  Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature.

Authors:  B J Currie; D A Fisher; D M Howard; J N Burrow; D Lo; S Selva-Nayagam; N M Anstey; S E Huffam; P L Snelling; P J Marks; D P Stephens; G D Lum; S P Jacups; V L Krause
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

Review 4.  Melioidosis.

Authors:  David A B Dance
Journal:  Curr Opin Infect Dis       Date:  2002-04       Impact factor: 4.915

5.  Intracellular survival of Burkholderia pseudomallei.

Authors:  A L Jones; T J Beveridge; D E Woods
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 6.  Melioidosis.

Authors:  N J White
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

Review 7.  Pulmonary melioidosis.

Authors:  M Ip; L G Osterberg; P Y Chau; T A Raffin
Journal:  Chest       Date:  1995-11       Impact factor: 9.410

8.  Enzyme-linked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis.

Authors:  L R Ashdown; R W Johnson; J M Koehler; C A Cooney
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

Review 9.  Recent development in melioidosis.

Authors:  Amorn Leelarasamee
Journal:  Curr Opin Infect Dis       Date:  2004-04       Impact factor: 4.915

10.  Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense.

Authors:  D P Speert; M Bond; R C Woodman; J T Curnutte
Journal:  J Infect Dis       Date:  1994-12       Impact factor: 5.226

View more
  8 in total

1.  Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India.

Authors:  Amit Rawat; Pandiarajan Vignesh; Avinash Sharma; Jitendra K Shandilya; Madhubala Sharma; Deepti Suri; Anju Gupta; Vikas Gautam; Pallab Ray; Shivaprakash M Rudramurthy; Arunaloke Chakrabarti; Kohsuke Imai; Shigeaki Nonoyama; Osamu Ohara; Yu L Lau; Surjit Singh
Journal:  J Clin Immunol       Date:  2017-03-22       Impact factor: 8.317

2.  Burkholderia glumae infection in an infant with chronic granulomatous disease.

Authors:  Jason B Weinberg; Barbara D Alexander; Joseph M Majure; Larry W Williams; Jason Y Kim; Peter Vandamme; John J LiPuma
Journal:  J Clin Microbiol       Date:  2006-11-29       Impact factor: 5.948

3.  Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice.

Authors:  Katrin Breitbach; Sonja Klocke; Thomas Tschernig; Nico van Rooijen; Ulrich Baumann; Ivo Steinmetz
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

4.  Severe X-linked chronic granulomatous disease in two unrelated females.

Authors:  Sylvie Chollet-Martin; Anne Lopez; Catherine Gaud; Dominique Henry; Bertrand Stos; Jamel El Benna; Gaëlle Chedevile; Dominique Gendrel; Marie-Anne Gougerot-Pocidalo; Bernard Grandchamp; Bénédicte Gérard
Journal:  Eur J Pediatr       Date:  2006-11-03       Impact factor: 3.183

5.  Interaction of Interferon gamma-induced reactive oxygen species with ceftazidime leads to synergistic killing of intracellular Burkholderia pseudomallei.

Authors:  Kara Mosovsky; Ediane Silva; Ryan Troyer; Katie Propst-Graham; Steven Dow
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

6.  Development of vaccines against burkholderia pseudomallei.

Authors:  Natasha Patel; Laura Conejero; Melanie De Reynal; Anna Easton; Gregory J Bancroft; Richard W Titball
Journal:  Front Microbiol       Date:  2011-09-27       Impact factor: 5.640

7.  Variant of X-Linked Chronic Granulomatous Disease Revealed by a Severe Burkholderia cepacia Invasive Infection in an Infant.

Authors:  Saul Oswaldo Lugo Reyes; Nizar Mahlaoui; Carolina Prando; Lizbeth Blancas Galicia; Marjorie Hubeau; Stéphane Blanche; Capucine Picard; Jean-Laurent Casanova; Jacinta Bustamante
Journal:  Case Reports Immunol       Date:  2013-07-21

8.  Hypothetical Protein BPSL3393 of Burkholderia pseudomallei is Involved in Ethanolamine Catabolism.

Authors:  Ooi Gim Luan; Hokchai Yam; Razip Samian; Mustafa Fadzil Farid Wajidi; Nor Muhammad Mahadi; Suriani Mohamad; Nazalan Najimudin
Journal:  Trop Life Sci Res       Date:  2017-07-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.